BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 44
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (28781)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.
Item 
Count 
PDF1136
WORD221
HTML23023
Figures (1-3)285
Tables (1-1)247
 Sum=24912
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse661
Download1345
 Sum=2006
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1197
Download666
 Sum=1863
Nov 28, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol 2014; 20(44): 16452-16463 [PMID: PMC4248188 DOI: 10.3748/wjg.v20.i44.16452]
URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16452.htm
Number Citing Articles
1
N. Esser, N. Paquot, A. J. Scheen. Inflammatory markers and cardiometabolic diseases. Acta Clinica Belgica 2015; 70(3): 193 doi: 10.1179/2295333715Y.0000000004
2
Josilda Ferreira CRUZ, Yasmim Anayr Costa FERRARI, Carla Perez MACHADO, Nathalia Nascimento SANTANA, Allan Victor Hora MOTA, Sonia Oliveira LIMA. SARCOPENIA AND SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE. Arquivos de Gastroenterologia 2019; 56(4): 357 doi: 10.1590/s0004-2803.201900000-66
3
Xueliang Wang, Di Liu, Zhe Wang, Chao Cai, Hao Jiang, Guangli Yu. Porphyran‐derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. The FASEB Journal 2021; 35(6) doi: 10.1096/fj.202000763RRR
4
Effect of dark environment on intestinal flora and expression of genes related to liver metabolism in zebrafish (Danio rerio). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021; 249: 109100 doi: 10.1016/j.cbpc.2021.109100
5
Priscila Vaz de Melo Ribeiro, Tomas Gomes Veloso, Leandro Licursi de Oliveira, Nélia Pinheiro Mendes, Rita de Cássia Gonçalves Alfenas. Consumption of yacon flour and energy-restricted diet increased the relative abundance of intestinal bacteria in obese adults. Brazilian Journal of Microbiology 2023; 54(4): 3085 doi: 10.1007/s42770-023-01140-w
6
Rok Orel, Lea Vodušek Reberšak. Probiotics, Prebiotics, and Synbiotics. 2016; : 181 doi: 10.1016/B978-0-12-802189-7.00012-5
7
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver disease. Nutrition & Food Science 2019; 49(1): 75 doi: 10.1108/NFS-04-2018-0119
8
Hyun Jin Bae, Sung Taek Kim, Seung Goun Hong, Hyunjeong Lee, Hyo Sun Choi, Yoo-kyung Cho, Tae Hyung Kim, Sook Hee Chung. Risk Factors for Asymptomatic Colon Diverticulosis. The Korean Journal of Gastroenterology 2019; 74(3): 142 doi: 10.4166/kjg.2019.74.3.142
9
Ignatius H. Sirikyi, Sebastian Eliason, Frank N. Ghartey, Evans Ekenam, Kingsley K. A. Pereko, Emmanuel Okai, Felix Yiridong, Oheneba C. K. Hagan, Paul Nsiah. Anthropometric indices and cardiometabolic risk factors in a Ghanaian adolescent population. Journal of Pediatric Endocrinology and Metabolism 2021; 34(1): 35 doi: 10.1515/jpem-2020-0273
10
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Calina, Javad Sharifi-Rad. Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-02072-3
11
Naomi Fearon, Dimitri J. Pournaras. Obesity, Bariatric and Metabolic Surgery. 2023; : 1005 doi: 10.1007/978-3-030-60596-4_107
12
Ziyu Jiang, Joe Antony Jacob, Jianyue Li, Xiahui Wu, Guoli Wei, ArunPrasanna Vimalanathan, Rajesh Mani, Prasannabalaji Nainangu, Uma Maheshwari Rajadurai, Baoan Chen. Influence of diet and dietary nanoparticles on gut dysbiosis. Microbial Pathogenesis 2018; 118: 61 doi: 10.1016/j.micpath.2018.03.017
13
Yu Qian, Mingyue Li, Wei Wang, Hongwei Wang, Yu Zhang, Qiang Hu, Xin Zhao, Huayi Suo. Effects of Lactobacillus Casei YBJ02 on Lipid Metabolism in Hyperlipidemic Mice. Journal of Food Science 2019; 84(12): 3793 doi: 10.1111/1750-3841.14787
14
Pengyi Zhang, Weiya Wang, Min Mao, Ruolin Gao, Wenting Shi, Dongmei Li, Richard Calderone, Bo Sui, Xuewen Tian, Xiangjing Meng. Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.710285
15
Syeda Momna Ishtiaq, Haroon Rashid, Zulfia Hussain, Muhammad Imran Arshad, Junaid Ali Khan. Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease. Reviews in Endocrine and Metabolic Disorders 2019; 20(3): 253 doi: 10.1007/s11154-019-09510-2
16
Tsutomu Yoshihara, Yosuke Oikawa, Takayuki Kato, Takaomi Kessoku, Takashi Kobayashi, Shingo Kato, Noboru Misawa, Keiichi Ashikari, Akiko Fuyuki, Hidenori Ohkubo, Takuma Higurashi, Yoko Tateishi, Yoshiki Tanaka, Shunji Nakajima, Hiroshi Ohno, Koichiro Wada, Atsushi Nakajima. The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin. Gut Microbes 2020; 11(5): 1385 doi: 10.1080/19490976.2020.1758290
17
Nazarii Kobyliak, Tetyana Falalyeyeva, Oleksandr Virchenko, Galyna Mykhalchyshyn, Petro Bodnar, Mykola Spivak, Dmytro Yankovsky, Tetyana Beregova, Lyudmyla Ostapchenko. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0451-2
18
Jordan E. Lake, Turner Overton, Susanna Naggie, Mark Sulkowski, Rohit Loomba, David E. Kleiner, Jennifer C. Price, Kara W. Chew, Raymond T. Chung, Kathleen E. Corey. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. Clinical Gastroenterology and Hepatology 2022; 20(2): 256 doi: 10.1016/j.cgh.2020.10.018
19
L. I. Elvira-Torales, M. J. Periago, R. González-Barrio, N. Hidalgo, I. Navarro-González, C. Gómez-Gallego, D. Masuero, E. Soini, U. Vrhovsek, F. J. García-Alonso. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). Food & Function 2019; 10(4): 2148 doi: 10.1039/C8FO01630E
20
David Niederseer, Bernhard Wernly, Elmar Aigner, Felix Stickel, Christian Datz. NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. Journal of Clinical Medicine 2021; 10(3): 467 doi: 10.3390/jcm10030467
21
David S. H. Bell. Changes seen in gut bacteria content and distribution with obesity: causation or association?. Postgraduate Medicine 2015; 127(8): 863 doi: 10.1080/00325481.2015.1098519
22
Somaya A. M. Albhaisi, Jasmohan S. Bajaj, Arun J. Sanyal. Role of gut microbiota in liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G84 doi: 10.1152/ajpgi.00118.2019
23
Daryl Ramai, Antonio Facciorusso, Erika Vigandt, Bryan Schaf, Waleed Saadedeen, Aditya Chauhan, Sara di Nunzio, Aashni Shah, Luca Giacomelli, Rodolfo Sacco. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Cells 2021; 10(12): 3401 doi: 10.3390/cells10123401
24
Edgar Torres-Maravilla, Anne-Sophie Boucard, Amir Hossein Mohseni, Sedigheh Taghinezhad-S, Naima G. Cortes-Perez, Luis G. Bermúdez-Humarán. Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression. Microorganisms 2021; 9(5): 1021 doi: 10.3390/microorganisms9051021
25
Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, Nik Aina Syazana Nik Zainuddin, Mohd Rahimi Ashraf Abd Rahman, Siti Khadijah Mustapha Kamal, Norizah Awang, Hussin Muhammad. A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation. Current Issues in Molecular Biology 2024; 46(10): 11460 doi: 10.3390/cimb46100682
26
Senthilkumar Sankararaman, Kimberly Noriega, Sujithra Velayuthan, Thomas Sferra, Robert Martindale. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders. Current Gastroenterology Reports 2023; 25(2): 31 doi: 10.1007/s11894-022-00859-0
27
Hyunwook Koh, Yutong Li, Xiang Zhan, Jun Chen, Ni Zhao. A Distance-Based Kernel Association Test Based on the Generalized Linear Mixed Model for Correlated Microbiome Studies. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00458
28
Juan Jovel, Jordan Patterson, Weiwei Wang, Naomi Hotte, Sandra O'Keefe, Troy Mitchel, Troy Perry, Dina Kao, Andrew L. Mason, Karen L. Madsen, Gane K.-S. Wong. Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.00459
29
Xiaolin Gao, Yu Zhu, Yang Wen, Guanjian Liu, Chaomin Wan. Efficacy of probiotics in non‐alcoholic fatty liver disease in adult and children: A meta‐analysis of randomized controlled trials. Hepatology Research 2016; 46(12): 1226 doi: 10.1111/hepr.12671
30
Margaret Gasta. Integrative and Functional Medical Nutrition Therapy. 2020; : 99 doi: 10.1007/978-3-030-30730-1_8
31
Hessam Yaghmaei, Seyed Ali Nojoumi, Masood Soltanipur, Hossein Yarmohammadi, Seyed Mohsen Mirhosseini, Mahdi Rezaei, Mohammadreza Jalali Nadoushan, Seyed Davar Siadat. The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Obesity Medicine 2024; 50: 100551 doi: 10.1016/j.obmed.2024.100551
32
Ewa Stachowska, Karina Ryterska, Dominika Maciejewska, Marcin Banaszczak, Piotr Milkiewicz, Małgorzata Milkiewicz, Izabela Gutowska, Piotr Ossowski, Małgorzata Kaczorowska, Dominika Jamioł-Milc, Anna Sabinicz, Małgorzata Napierała, Lidia Wądołowska, Joanna Raszeja-Wyszomirska. Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). International Journal of Molecular Sciences 2016; 17(7): 1192 doi: 10.3390/ijms17071192
33
Lijun Wang, Yu-Jui Yvonne Wan. The role of gut microbiota in liver disease development and treatment. Liver Research 2019; 3(1): 3 doi: 10.1016/j.livres.2019.02.001
34
María Luna-Luna, Aida Medina-Urrutia, Gilberto Vargas-Alarcón, Fernanda Coss-Rovirosa, Jesús Vargas-Barrón, Óscar Pérez-Méndez. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis. Archives of Medical Research 2015; 46(5): 392 doi: 10.1016/j.arcmed.2015.05.007
35
So Young Park, Morena Ustulin, SangHyun Park, Kyung-Do Han, Joo Young Kim, Dong Wook Shin, Sang Youl Rhee. Systemic Antibiotics and Obesity: Analyses from a Population-Based Cohort. Journal of Clinical Medicine 2021; 10(12): 2601 doi: 10.3390/jcm10122601
36
Fernando Magdaleno, Maximilian Joseph Brol, Robert Schierwagen, Frank Erhard Uschner, Michael Zwick, Jonel Trebicka. The Human Gut-Liver-Axis in Health and Disease. 2019; : 235 doi: 10.1007/978-3-319-98890-0_14
37
James W O'Brien, Nabeel Merali, Chris Pring, Tim Rockall, Denise Robertson, David Bartlett, Adam Frampton. Gastrointestinal Permeability After Bariatric Surgery: A Systematic Review. Cureus 2024;  doi: 10.7759/cureus.60480
38
Wenshu Liu, Xiaoze Guo, Yanliang Chen, Yanqiang Tang, Haihong Xiao, Yuzhu Wang, Siming Li, Zhigang Zhou. Effects of choline chloride on intestinal microbiota and its association with liver fat accumulation in zebrafish. Aquaculture Reports 2022; 24: 101096 doi: 10.1016/j.aqrep.2022.101096
39
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Comprehensive Gut Microbiota. 2022; : 475 doi: 10.1016/B978-0-12-819265-8.00079-6
40
Stella Baliou, Maria Adamaki, Demetrios Spandidos, Anthony Kyriakopoulos, Ioannis Christodoulou, Vassilis Zoumpourlis. The microbiome, its molecular mechanisms and its potential as a therapeutic strategy against colorectal carcinogenesis (Review). World Academy of Sciences Journal 2018; 1(1): 3 doi: 10.3892/wasj.2018.6
41
Samuel Snyder, Natassja Gangeri. Obesity. 2016; : 181 doi: 10.1007/978-3-319-19821-7_14
42
Vikas Uppal, Sana Mansoor, Katryn N. Furuya. Pediatric Non-alcoholic Fatty Liver Disease. Current Gastroenterology Reports 2016; 18(5) doi: 10.1007/s11894-016-0498-9
43
Valeria García-Castillo, Enrique Sanhueza, Eileen McNerney, Sergio A. Onate, Apolinaria García. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle.  Journal of Medical Microbiology 2016; 65(12): 1347 doi: 10.1099/jmm.0.000371
44
Aneta Stachowicz, Klaudia Czepiel, Anna Wiśniewska, Kamila Stachyra, Magdalena Ulatowska-Białas, Beata Kuśnierz-Cabala, Marcin Surmiak, Grzegorz Majka, Katarzyna Kuś, Mark E. Wood, Roberta Torregrossa, Matthew Whiteman, Rafał Olszanecki. Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways. Pharmacological Research 2024; 209: 107428 doi: 10.1016/j.phrs.2024.107428
45
Jyotsna Talreja Wassan, Haiying Wang, Fiona Browne, Huiru Zheng. A Comprehensive Study on Predicting Functional Role of Metagenomes Using Machine Learning Methods. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2019; 16(3): 751 doi: 10.1109/TCBB.2018.2858808
46
Sandica Bucurica. A Comprehensive Guide to Nonalcoholic Fatty Liver Disease [Working Title]. 2024;  doi: 10.5772/intechopen.1008148
47
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
48
David Bradley. Lipidomic Profiling Informs Study of Metabolism-Related Diseases. Genetic Engineering & Biotechnology News 2022; 42(11): 28 doi: 10.1089/gen.42.11.10
49
Roberta Forlano, Mathuri Sivakumar, Benjamin H. Mullish, Pinelopi Manousou. Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review. International Journal of Molecular Sciences 2022; 23(15): 8307 doi: 10.3390/ijms23158307
50
Raquel Coronato Nunes, Ana Luiza Gomes Moura, Arthur Lawall Silva, Gustavo Gusman Oliveira, Luisa Artiaga Malta, Rodrigo Oliveira Moreira. Avaliação da frequência de deficiência de vitamina D em pacientes com obesidade. HU Revista 2019; 44(2): 175 doi: 10.34019/1982-8047.2018.v44.13966
51
Yan Wan, Jia Xia, Jin-feng Xu, Lu Chen, Yu Yang, Jiao-Jiao Wu, Fei Tang, Hui Ao, Cheng Peng. Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases. Pharmacological Research 2022; 175: 106002 doi: 10.1016/j.phrs.2021.106002
52
Zhihua Niu, Meijuan Zou, Tingting Bei, Na Zhang, Dongyao Li, Miaoshu Wang, Chen Li, Hongtao Tian. Effect of fructooligosaccharides on the colonization of Lactobacillus rhamnosus AS 1.2466T in the gut of mice. Food Science and Human Wellness 2023; 12(2): 607 doi: 10.1016/j.fshw.2022.07.063
53
Mariangela Rondanelli, Sara Borromeo, Alessandro Cavioni, Clara Gasparri, Ilaria Gattone, Elisa Genovese, Alessandro Lazzarotti, Leonardo Minonne, Alessia Moroni, Zaira Patelli, Claudia Razza, Claudia Sivieri, Eugenio Marzio Valentini, Gaetan Claude Barrile. Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management. Metabolites 2025; 15(2): 127 doi: 10.3390/metabo15020127
54
Marina Rodrigues, Caroline Bertoncini-Silva, Anderson Gregorio Joaquim, Cássia Dias Machado, Leandra Náira Zambelli Ramalho, Daniela Carlos, Priscila Giacomo Fassini, Vivian Marques Miguel Suen. Beneficial effects of eugenol supplementation on gut microbiota and hepatic steatosis in high-fat-fed mice. Food & Function 2022; 13(6): 3381 doi: 10.1039/D1FO03619J
55
Yu Yang, Jiakun Miao, Juan Du, Shuang Xu, Kaiyi Zhang, Tianwen Wu, Cong Tao, Yanfang Wang, Meiying Fang, Shulin Yang. Deficiency of SLC26A3 promotes jejunal barrier damage in metabolic disease-susceptible transgenic pigs. International Journal of Biological Macromolecules 2024; 281: 136245 doi: 10.1016/j.ijbiomac.2024.136245
56
Eric H. Bernicker, Eamonn M.M. Quigley. The Gut Microbiome Influences Responses to Programmed Death 1 Therapy in Chinese Lung Cancer Patients — the Benefits of Diversity. Journal of Thoracic Oncology 2019; 14(8): 1319 doi: 10.1016/j.jtho.2019.05.016
57
Robert Caesar, Heli Nygren, Matej Orešič, Fredrik Bäckhed. Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. Journal of Lipid Research 2016; 57(3): 474 doi: 10.1194/jlr.M065847
58
Xin Chu, Qunyan Jin, Hui Chen, G. Craig Wood, Anthony Petrick, William Strodel, Jon Gabrielsen, Peter Benotti, Tooraj Mirshahi, David J. Carey, Christopher D. Still, Johanna K. DiStefano, Glenn S. Gerhard. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1490-y
59
Priti Devi, Azka Khan, Partha Chattopadhyay, Aarushi Garg, Rajesh Pandey. Comprehensive Gut Microbiota. 2022; : 400 doi: 10.1016/B978-0-12-819265-8.00080-2
60
А.Е. Абатуров, А.А. Никулина. Antibiotic Therapy as a Risk Factor of Obesity Development in Children. Педиатрия. Восточная Европа 2020; (2): 268 doi: 10.34883/PI.2020.8.2.013
61
Naomi Fearon, Dimitri Pournaras. Obesity, Bariatric and Metabolic Surgery. 2022; : 1 doi: 10.1007/978-3-030-54064-7_107-1
62
Paul R. Afolabi, Eleonora Scorletti, Philip C. Calder, Christopher D. Byrne. Factors independently associated with cardiorespiratory fitness in patients with non‐alcoholic fatty liver disease. Liver International 2020; 40(12): 2998 doi: 10.1111/liv.14618
63
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
64
Codrina-Madalina Palade, Georgiana-Anca Vulpoi, Radu-Alexandru Vulpoi, Vasile Liviu Drug, Oana-Bogdana Barboi, Manuela Ciocoiu. The Biotics Family: Current Knowledge and Future Perspectives in Metabolic Diseases. Life 2022; 12(8): 1263 doi: 10.3390/life12081263
65
Aftab Ahmed, Khadija Maham, Muhammad Afzaal, Muhammad Awais Saleem, Muhammad Nadeem, Farhan Saeed, Muzzamal Hussain, Entessar Al Jbawi. The consequences of poor dietary patterns on the proliferation of non-alcoholic fatty liver disease. Cogent Food & Agriculture 2024; 10(1) doi: 10.1080/23311932.2024.2325206
66
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7): 412 doi: 10.1038/nrgastro.2016.85
67
Xiaona Liu, Shifeng Wang, Zhisheng Wu, Zhaoyi Wang, Qiusheng Zheng, Defang Li. Deoxyschizandrin Loaded Liposomes on the Suppression Lipid Accumulation in 3T3-L1 Adipocytes. Molecules 2018; 23(9): 2158 doi: 10.3390/molecules23092158
68
Miao Wang, Baojie Zhang, Jielun Hu, Shaoping Nie, Tao Xiong, Mingyong Xie. Intervention of five strains of Lactobacillus on obesity in mice induced by high-fat diet. Journal of Functional Foods 2020; 72: 104078 doi: 10.1016/j.jff.2020.104078
69
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
70
Lan Zhao, Susan M Grimes, Stephanie U Greer, Matthew Kubit, HoJoon Lee, Lincoln D Nadauld, Hanlee P Ji. Characterization of the consensus mucosal microbiome of colorectal cancer. NAR Cancer 2021; 3(4) doi: 10.1093/narcan/zcab049
71
Ritesh Chimoriya, Milan K Piya, David Simmons, Golo Ahlenstiel, Vincent Ho. The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 10(1): 95 doi: 10.3390/jcm10010095
72
Soo Lim, Jin-Wook Kim, Giovanni Targher. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends in Endocrinology & Metabolism 2021; 32(7): 500 doi: 10.1016/j.tem.2021.04.008
73
Luciano Pedro Da Silva Junior, Rafaela Bezerra Rovai, Joyce Josilene De Rezende, Bruna Gonçalves Das Mercês, Caroline Bianca Ferreira Teixeira Da Silva, Deborah Cristina Landi Masquio. Microbiota intestinal e síndrome metabólica: utilização terapêutica de probióticos. Revista da Associação Brasileira de Nutrição - RASBRAN 2023; 13(1): 1 doi: 10.47320/rasbran.2022.1451
74
Iván López-Méndez, Karla Méndez-Maldonado, Luis A. Manzo-Francisco, Eva Juárez-Hernández, Misael Uribe, Varenka J. Barbero-Becerra. G protein-coupled receptors: Key molecules in metabolic associated fatty liver disease development. Nutrition Research 2021; 87: 70 doi: 10.1016/j.nutres.2020.12.019
75
Lukasz Kaska, Tomasz Sledzinski, Agnieszka Chomiczewska, Agnieszka Dettlaff-Pokora, Julian Swierczynski. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World Journal of Gastroenterology 2016; 22(39): 8698-8719 doi: 10.3748/wjg.v22.i39.8698
76
Ming Xie, Haokai Tang, Feifei Li, Si Wu, Yanhui Dong, Yide Yang, Julien Steven Baker, Jun Ma. Mediating Roles of hsCRP, TNF-α and Adiponectin on the Associations between Body Fat and Fatty Liver Disease among Overweight and Obese Adults. Biology 2021; 10(9): 895 doi: 10.3390/biology10090895
77
Hitoshi Watanabe, Yuka Inaba, Kumi Kimura, Shun-ichiro Asahara, Yoshiaki Kido, Michihiro Matsumoto, Takayasu Motoyama, Nobuhiko Tachibana, Shuichi Kaneko, Mitsutaka Kohno, Hiroshi Inoue. Dietary Mung Bean Protein Reduces Hepatic Steatosis, Fibrosis, and Inflammation in Male Mice with Diet-Induced, Nonalcoholic Fatty Liver Disease. The Journal of Nutrition 2017; 147(1): 52 doi: 10.3945/jn.116.231662
78
Ioannis Alexandros Charitos, Maria Aliani, Pasquale Tondo, Maria Venneri, Giorgio Castellana, Giulia Scioscia, Francesca Castellaneta, Donato Lacedonia, Mauro Carone. Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome. International Journal of Molecular Sciences 2024; 25(5): 2841 doi: 10.3390/ijms25052841
79
Ze Hua Zhao, Jonathan King‐Lam Lai, Liang Qiao, Jian Gao Fan. Role of gut microbial metabolites in nonalcoholic fatty liver disease. Journal of Digestive Diseases 2019; 20(4): 181 doi: 10.1111/1751-2980.12709
80
Vincenzo Di Pilato, Giancarlo Freschi, Maria Novella Ringressi, Lucia Pallecchi, Gian Maria Rossolini, Paolo Bechi. The esophageal microbiota in health and disease. Annals of the New York Academy of Sciences 2016; 1381(1): 21 doi: 10.1111/nyas.13127
81
Jian-Hong Ding, Zhe Jin, Xiao-Xu Yang, Jun Lou, Wei-Xi Shan, Yan-Xia Hu, Qian Du, Qiu-Shi Liao, Rui Xie, Jing-Yu Xu. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World Journal of Gastroenterology 2020; 26(40): 6141-6162 doi: 10.3748/wjg.v26.i40.6141
82
Huijun He, Yonggan Sun, Shanshan Zhang, Hao Zhang, Wenwen Su, Zheyu Guo, Yanli Zhang, Jiajia Wen, Xiajialong Li, Jielun Hu, Shaoping Nie. Arabinogalactan, Bifidobacterium longum, and Faecalibacterium prausnitzii improve insulin resistance in high‐fat diet‐induced C57BL/6J mice. eFood 2022; 3(1-2) doi: 10.1002/efd2.1
83
Rui Li, Zhengsheng Mao, Xujun Ye, Tao Zuo. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021; 9(5): 1017 doi: 10.3390/microorganisms9051017
84
Magdalena Maj, Brooke Harbottle, Payton A Thomas, Gabriella V Hernandez, Victoria A Smith, Mark S Edwards, Rob K Fanter, Hunter S Glanz, Chad Immoos, Douglas G Burrin, Tasha M Santiago-Rodriguez, Michael R La Frano, Rodrigo Manjarín. Consumption of High-Fructose Corn Syrup Compared with Sucrose Promotes Adiposity and Increased Triglyceridemia but Comparable NAFLD Severity in Juvenile Iberian Pigs. The Journal of Nutrition 2021; 151(5): 1139 doi: 10.1093/jn/nxaa441
85
Na Ao, Jian Du, Shi Jin, Linna Suo, Jing Yang. The cellular and molecular mechanisms mediating the protective effects of sodium–glucose linked transporter 2 inhibitors against metabolic dysfunction‐associated fatty liver disease. Diabetes, Obesity and Metabolism 2025; 27(2): 457 doi: 10.1111/dom.16043
86
G. Adrienne Weiss, Thierry Hennet. Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences 2017; 74(16): 2959 doi: 10.1007/s00018-017-2509-x
87
Milton Tshidiso Mogotsi, Ayodeji Emmanuel Ogunbayo, Phillip Armand Bester, Hester Gertruida O'Neill, Martin Munene Nyaga. Longitudinal analysis of the enteric virome in paediatric subjects from the Free State Province, South Africa, reveals early gut colonisation and temporal dynamics. Virus Research 2024; 346: 199403 doi: 10.1016/j.virusres.2024.199403
88
Jianping Jiang, Li Yan, Zheng Shi, Lixia Wang, Letian Shan, Thomas Efferth. Hepatoprotective and anti-inflammatory effects of total flavonoids of Qu Zhi Ke (peel of Citrus changshan-huyou) on non-alcoholic fatty liver disease in rats via modulation of NF-κB and MAPKs. Phytomedicine 2019; 64: 153082 doi: 10.1016/j.phymed.2019.153082
89
Ivo P. van de Peppel, Frank A.J.A. Bodewes, Henkjan J. Verkade, Johan W. Jonker. Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis. Journal of Cystic Fibrosis 2019; 18(3): 313 doi: 10.1016/j.jcf.2018.08.009
90
Winda P. Bastian, Irsan Hasan, C. Rinaldi A. Lesmana, Ikhwan Rinaldi, Rino A. Gani. Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases. Case Reports in Gastroenterology 2019; 13(1): 125 doi: 10.1159/000498946
91
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.903570
92
Anna Kiepura, Kamila Stachyra, Rafał Olszanecki. Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4). Biomedicines 2021; 9(5): 467 doi: 10.3390/biomedicines9050467
93
Sukrit Kanchanasurakit, Chayanis Kositamongkol, Kamonnat Lanoi, Monnaree Nunta, Thaksaporn Saetuan, Nathorn Chaiyakunapruk, Surasak Saokaew, Pochamana Phisalprapa. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.880014
94
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
95
Jun Sung Moon, Jun Hwa Hong, Yong Jin Jung, Ele Ferrannini, Michael A. Nauck, Soo Lim. SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. Trends in Endocrinology & Metabolism 2022; 33(6): 424 doi: 10.1016/j.tem.2022.03.005
96
Soo Lim, Marja‐Riitta Taskinen, Jan Borén. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obesity Reviews 2019; 20(4): 599 doi: 10.1111/obr.12820
97
Vijayakumar Natesan, Sung-Jin Kim. Lipid Metabolism, Disorders and Therapeutic Drugs - Review. Biomolecules & Therapeutics 2021; 29(6): 596 doi: 10.4062/biomolther.2021.122
98
Bo Kyung Koo, Soo Lim. Clinical Obesity in Adults and Children. 2022; : 159 doi: 10.1002/9781119695257.ch13
99
Eider Talavera-Urquijo, Marc Beisani, José M. Balibrea, John C. Alverdy. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. Surgery for Obesity and Related Diseases 2020; 16(9): 1361 doi: 10.1016/j.soard.2020.03.013
100
Tong-Yan Liu, Xiao-Qing Xiong, Xing-Sheng Ren, Ming-Xia Zhao, Chang-Xiang Shi, Jue-Jin Wang, Ye-Bo Zhou, Feng Zhang, Ying Han, Xing-Ya Gao, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice. Diabetes 2016; 65(11): 3262 doi: 10.2337/db16-0356
101
Subhamay Adhikary, Akanksha Esmeeta, Amit Dey, Antara Banerjee, Biki Saha, Pournami Gopan, Asim K. Duttaroy, Surajit Pathak. Impacts of gut microbiota alteration on age-related chronic liver diseases. Digestive and Liver Disease 2024; 56(1): 112 doi: 10.1016/j.dld.2023.06.017
102
S. Guercio Nuzio, M. Di Stasi, L. Pierri, J. Troisi, M. Poeta, A. Bisogno, F. Belmonte, M. Tripodi, D. Di Salvio, G. Massa, R. Savastano, P. Cavallo, M. Boffardi, D. Ziegenhardt, I. Bergheim, C. Mandato, P. Vajro. Multiple gut–liver axis abnormalities in children with obesity with and without hepatic involvement. Pediatric Obesity 2017; 12(6): 446 doi: 10.1111/ijpo.12164
103
Piero Portincasa, Mohamad Khalil, Annarita Graziani, Gema Frühbeck, Gyorgy Baffy, Gabriella Garruti, Agostino Di Ciaula, Leonilde Bonfrate. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?. European Journal of Internal Medicine 2024; 119: 13 doi: 10.1016/j.ejim.2023.10.002
104
Dureen Samandar Eweis, Fida Abed, Johnny Stiban. Carbon dioxide in carbonated beverages induces ghrelin release and increased food consumption in male rats: Implications on the onset of obesity. Obesity Research & Clinical Practice 2017; 11(5): 534 doi: 10.1016/j.orcp.2017.02.001
105
Monica M. Betancourt-Garcia, Armando Arguelles, Jorge Montes, Ambrosio Hernandez, Manish Singh, R. Armour Forse. Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children. Obesity Surgery 2017; 27(1): 236 doi: 10.1007/s11695-016-2440-5
106
Xin Zhou, Dewu Han, Ruiling Xu, Huiwen Wu, Chongxiao Qu, Feng Wang, Xiangyu Wang, Yuanchang Zhao. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. Oncotarget 2016; 7(49): 80223 doi: 10.18632/oncotarget.12831
107
Teresa Auguet, Laia Bertran, Jessica Binetti. Human Microbiome. Biochemistry 2021; 20 doi: 10.5772/intechopen.92972
108
Sabri Rial, Antony Karelis, Karl-F. Bergeron, Catherine Mounier. Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. Nutrients 2016; 8(5): 281 doi: 10.3390/nu8050281
109
Ann Catherine Archer. Probiotic Research in Therapeutics. 2021; : 1 doi: 10.1007/978-981-33-6236-9_1
110
Cosmas Rinaldi Adithya Lesmana, Mutiara Lirendra, Laurentius Adrianto Lesmana. Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice. Annals of Colorectal Research 2019; (In Press) doi: 10.5812/acr.88488
111
Iris Pinheiro, Aurora Barberá, Imma Raurell, Federico Estrella, Marcel de Leeuw, Selin Bolca, Davide Gottardi, Nigel Horscroft, Sam Possemiers, María Teresa Salcedo, Joan Genescà, María Martell, Salvador Augustin. A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. Biomedicines 2022; 10(5): 1191 doi: 10.3390/biomedicines10051191
112
Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang. Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice. Foods 2022; 11(14): 2169 doi: 10.3390/foods11142169
113
Han Lü, Xiuhua Meng, Xiaoqin Ding, Tunyu Jian, Yuanyuan Zuo, Yan Liu, Bingru Ren, Weilin Li, Jian Chen. Gallotannin Isolated from Pericarp of Water Caltrop Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Journal of Agricultural and Food Chemistry 2023; 71(18): 7046 doi: 10.1021/acs.jafc.3c01099
114
Karen S. W. Leong, José G. B. Derraik, Paul L. Hofman, Wayne S. Cutfield. Antibiotics, gut microbiome and obesity. Clinical Endocrinology 2018; 88(2): 185 doi: 10.1111/cen.13495
115
Giovanni Tarantino, Vincenzo Citro, Domenico Capone. Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. Journal of Clinical Medicine 2019; 9(1): 15 doi: 10.3390/jcm9010015
116
Tünde Kovács, Edit Mikó, Gyula Ujlaki, Zsanett Sári, Péter Bai. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1225: 137 doi: 10.1007/978-3-030-35727-6_10
117
Victor Hugo Dantas Guimarães, Barbhara Mota Marinho, Daisy Motta-Santos, Gabriela da Rocha Lemos Mendes, Sérgio Henrique Sousa Santos. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome. The Journal of Nutritional Biochemistry 2023; 113: 109252 doi: 10.1016/j.jnutbio.2022.109252
118
Bruno Donatini. Pullulation bactérienne du grêle. Intérêt des nouvelles technologies ambulatoires : test respiratoire couplé à l’élastométrie hépatique, à la recherche des herpès virus dans la salive ou de l’échographie gastro-intestinale. Principes thérapeutiques. Hegel 2015; (2): 92 doi: 10.3917/heg.052.0092
119
Guiping Wu, Zhenhui Li, Yun Zheng, Yihui Zhang, Long Liu, Daoqing Gong, Tuoyu Geng. Supplementing cholamine to diet lowers laying rate by promoting liver fat deposition and altering intestinal microflora in laying hens. Poultry Science 2022; 101(10): 102084 doi: 10.1016/j.psj.2022.102084
120
L.A. Kornoukhova, V.L. Emanuel, N.L. Denisov. Routine methods of laboratory studies of intestinal microbiota: role and place in clinical practice. Dokazatel'naya gastroenterologiya 2021; 10(4): 5 doi: 10.17116/dokgastro2021100415
121
Eun-Jung Park, You-Suk Lee, Sung Min Kim, Gun-Seok Park, Yong Hyun Lee, Do Yeun Jeong, Jihee Kang, Hae-Jeung Lee. Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats. Nutrients 2020; 12(2): 542 doi: 10.3390/nu12020542
122
Jayshree Mishra, Raj K. Verma, Gianfranco Alpini, Fanyin Meng, Narendra Kumar. Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome. Journal of Biological Chemistry 2015; 290(49): 29301 doi: 10.1074/jbc.M115.670331
123
Jordan E. Lake. The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection. Current HIV/AIDS Reports 2017; 14(6): 211 doi: 10.1007/s11904-017-0368-6
124
Iris Pinheiro. A Comprehensive Guide to Nonalcoholic Fatty Liver Disease [Working Title]. 2024;  doi: 10.5772/intechopen.1007741
125
Arianna K. DeGruttola, Daren Low, Atsushi Mizoguchi, Emiko Mizoguchi. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflammatory Bowel Diseases 2016; 22(5): 1137 doi: 10.1097/MIB.0000000000000750
126
H.C. Wei, S.J. Xing, P. Chen, X.F. Wu, X. Gu, L. Luo, X.F. Liang, M. Xue. Plant protein diet-induced hypoimmunity by affecting the spiral valve intestinal microbiota and bile acid enterohepatic circulation in Amur sturgeon (Acipenser schrenckii). Fish & Shellfish Immunology 2020; 106: 421 doi: 10.1016/j.fsi.2020.08.025
127
Alessia Angi, Francesco Chiarelli. Obesity and Diabetes: A Sword of Damocles for Future Generations. Biomedicines 2020; 8(11): 478 doi: 10.3390/biomedicines8110478
128
David R. Seaman. Toxins, Toxicity, and Endotoxemia: A Historical and Clinical Perspective for Chiropractors. Journal of Chiropractic Humanities 2016; 23(1): 68 doi: 10.1016/j.echu.2016.07.003
129
Hana Kiňová Sepová, Boris Dudík, Andrea Bilková. Gut microbiota: its development and relation to certain diseases. Česká a slovenská farmacie 2017; 66(6): 267 doi: 10.36290/csf.2017.038
130
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology. 2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
131
Lorena Elena Meliț, Cristina Oana Mărginean, Maria Oana Săsăran. The Yin-Yang Concept of Pediatric Obesity and Gut Microbiota. Biomedicines 2022; 10(3): 645 doi: 10.3390/biomedicines10030645
132
Emidio Scarpellini, Marialaura Scarcella, Jan F. Tack, Giuseppe Guido Maria Scarlata, Michela Zanetti, Ludovico Abenavoli. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease. Antioxidants 2024; 13(11): 1386 doi: 10.3390/antiox13111386
133
Zhi-Hong Luo, Meng-Wei Niu, Shen-Hai Gong, Guang-Yan Wu, Teng Wang, Fang-Zhao Wang, Guo-Quan Wei, Zhan-Ke He, Yong Jiang, Peng Chen. Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression protects against high fat diet-induced obesity and hepatic steatosis in mice. Chinese Medical Journal 2020; 133(15): 1805 doi: 10.1097/CM9.0000000000000915
134
Gabriel Olteanu, Maria-Alexandra Ciucă-Pană, Ștefan Sebastian Busnatu, Dumitru Lupuliasa, Sorinel Marius Neacșu, Magdalena Mititelu, Adina Magdalena Musuc, Corina-Bianca Ioniță-Mîndrican, Steluța Constanța Boroghină. Unraveling the Microbiome–Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications. International Journal of Molecular Sciences 2024; 25(10): 5561 doi: 10.3390/ijms25105561
135
Fernando Bessone, Melisa Dirchwolf, María Agustina Rodil, María Valeria Razori, Marcelo G. Roma. Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view. Alimentary Pharmacology & Therapeutics 2018; 48(9): 892 doi: 10.1111/apt.14952
136
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2): 167 doi: 10.34172/mejdd.2022.270
137
Yi Lyu, Lei Wu, Fang Wang, Xinchun Shen, Dingbo Lin. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis. Experimental Biology and Medicine 2018; 243(7): 613 doi: 10.1177/1535370218763760
138
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li. An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease. Engineering 2021; 7(5): 679 doi: 10.1016/j.eng.2020.01.017
139
Ping Qi, Jin Lv, Xiangdong Yan, Liuhui Bai, Lei Zhang. Microfluidics: Insights into Intestinal Microorganisms. Microorganisms 2023; 11(5): 1134 doi: 10.3390/microorganisms11051134
140
Marica Colella, Ioannis Alexandros Charitos, Andrea Ballini, Concetta Cafiero, Skender Topi, Raffaele Palmirotta, Luigi Santacroce. Microbiota revolution: How gut microbes regulate our lives. World Journal of Gastroenterology 2023; 29(28): 4368-4383 doi: 10.3748/wjg.v29.i28.4368
141
Sheeana Gangadoo, Huu Nguyen, Piumie Rajapaksha, Hala Zreiqat, Kay Latham, Daniel Cozzolino, James Chapman, Vi Khanh Truong. Inorganic nanoparticles as food additives and their influence on the human gut microbiota. Environmental Science: Nano 2021; 8(6): 1500 doi: 10.1039/D1EN00025J
142
Rong-Hong Hsieh, Yu-Ju Chien, Wen-Yi Lan, Yung-Kai Lin, Yung-Hsiang Lin, Chi-Fu Chiang, Ming-Ta Yang. Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial. Current Developments in Nutrition 2024; 8(3): 102083 doi: 10.1016/j.cdnut.2024.102083
143
Sandra Infante Villamil, Roger Huerlimann, Christina Morianos, Zoltan Sarnyai, Gregory E. Maes. Adverse effect of early-life high-fat/high-carbohydrate (“Western”) diet on bacterial community in the distal bowel of mice. Nutrition Research 2018; 50: 25 doi: 10.1016/j.nutres.2017.11.008
144
Cao Wubing, Du Yuqiong, Gao Lianyin, Che Niancong, Zhang Qiuyun, Fu Xiuwen, Luo Jiajia, Wang Rongbing. Lipopolysaccharide/Toll-like receptor 4 signaling pathway involved Qingdu decoction treating severe liver injury merging with endotoxemia. Journal of Traditional Chinese Medicine 2017; 37(3): 371 doi: 10.1016/S0254-6272(17)30073-0
145
Hyunwook Koh. An adaptive microbiome α-diversity-based association analysis method. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-36355-7
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345